These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2508981)

  • 1. A dual model for cardiac arrhythmias: coexistence of re-entry and abnormal automaticity and effects of antiarrhythmic agents.
    Wu KM; Hunter T; Proakis A
    Br J Pharmacol; 1989 Sep; 98(1):268-74. PubMed ID: 2508981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterisation of a re-entry model for atrial tachycardia in conscious dogs.
    Wu KM; Hunter T; Proakis A
    Cardiovasc Res; 1989 May; 23(5):400-9. PubMed ID: 2482130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
    Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
    Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
    Osadchii OE
    Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
    Hashimoto H; Katoh H; Nakashima M
    J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure.
    Stambler BS; Fenelon G; Shepard RK; Clemo HF; Guiraudon CM
    J Cardiovasc Electrophysiol; 2003 May; 14(5):499-507. PubMed ID: 12776867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flecainide, encainide, and clofilium on ventricular refractory period extension by transcardiac shocks.
    Sweeney RJ; Gill RM; Steinberg MI; Reid PR
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):50-60. PubMed ID: 8848377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP; van der Linde HJ; Van Deuren B; Somers Y; Lubomirski M; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2015; 72():72-84. PubMed ID: 25450838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual electrophysiologic test for atrial antireentry and ventricular antifibrillatory studies. Effects of bethanidine, procainamide, and WY-48986.
    Wu KM; Hunter TL; Proakis AG
    J Pharmacol Methods; 1990 Apr; 23(2):87-95. PubMed ID: 2332983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK; Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
    Gomoll AW
    Arzneimittelforschung; 1987 Jul; 37(7):787-94. PubMed ID: 3118889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monophasic action potentials during reentrant atrial flutter in the dog: effects of clofilium and acetylcholine.
    Wu KM; Ross S; Hoffman BF
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):908-14. PubMed ID: 2484086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a cardioselective M2 receptor antagonist, AF-DX 116, on ventricular arrhythmias in dogs.
    Naito H; Furukawa Y; Hashimoto K
    Heart Vessels; 1997; 12(5):229-33. PubMed ID: 9846808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of flecainide in a canine 7 day old myocardial infarction model.
    Sakai T; Ogawa S; Hosokawa M; Miyazaki T; Sakurai K; Nakamura Y
    Cardiovasc Res; 1989 Mar; 23(3):177-83. PubMed ID: 2512008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of anisotropy in determining the selective action of antiarrhythmics in atrial flutter in the dog.
    Yamashita T; Inoue H; Nozaki A; Kuo TT; Usui M; Sugimoto T
    Cardiovasc Res; 1992 Mar; 26(3):244-9. PubMed ID: 1423419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.